Reported Standalone quarterly numbers for Norris Medicines are:Net Sales at Rs 1.36 crore in March 2020 down 62.01% from Rs. 3.57 crore in March 2019.
Quarterly Net Loss at Rs. 0.55 crore in March 2020 down 162.63% from Rs. 0.88 crore in March 2019.
EBITDA stands negative at Rs. 0.84 crore in March 2020 down 148.55% from Rs. 1.73 crore in March 2019.
Norris Medicine shares closed at 2.95 on June 29, 2020 (BSE) and has given -22.37% returns over the last 6 months and -51.64% over the last 12 months.
| Norris Medicines | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 1.36 | 1.76 | 3.57 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.36 | 1.76 | 3.57 | | EXPENDITURE | | Consumption of Raw Materials | 1.74 | 0.98 | 1.44 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.80 | -0.16 | -0.38 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.73 | 0.88 | 0.19 | | Depreciation | 0.19 | 0.18 | 0.19 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.60 | 0.45 | 0.63 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.11 | -0.56 | 1.50 | | Other Income | 0.08 | 0.00 | 0.04 | | P/L Before Int., Excpt. Items & Tax | -1.03 | -0.56 | 1.54 | | Interest | 0.36 | 0.15 | 1.00 | | P/L Before Exceptional Items & Tax | -1.39 | -0.72 | 0.54 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.39 | -0.72 | 0.54 | | Tax | -0.84 | -- | -0.33 | | P/L After Tax from Ordinary Activities | -0.55 | -0.72 | 0.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.55 | -0.72 | 0.88 | | Equity Share Capital | 9.93 | 9.93 | 9.93 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.55 | -0.72 | 0.88 | | Diluted EPS | -0.55 | -0.72 | 0.88 | | EPS After Extra Ordinary | | Basic EPS | -0.55 | -0.72 | 0.88 | | Diluted EPS | -0.55 | -0.72 | 0.88 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Jun 30, 2020 09:37 am
